Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000270964.1 ABT-263 (navitoclax) Bladder urothelial carcinoma 0.01980562 Resistant
ENSG00000270964.1 ABT-263 (navitoclax) Esophageal cancer 0.035731769 Sensitive